FIELD: biotechnology.
SUBSTANCE: disclosed is a method of producing antigens from bacterial cell walls, comprising adding to cells of gram-positive cocci from the genera Staphylococcus and Streptococcus in amount of 1010 cells in an isotonic solution containing 30% mannitol, 10 mM MES with pH 6.5, 1 mM EDTA, 1 mM PMSF, oligochitosan with a weight-average molecular weight of 5 kDa in amount of 1 mcg; then the mixture is incubated for 15 minutes at 37 °C, bacterial protoplasts are separated by centrifugation at 2500 g for 5 minutes, the obtained antigen solution is dialyzed, concentrated and lyophilized.
EFFECT: invention provides a wider range of methods for producing antigens from cell walls of staphylococci and streptococci without using protein enzymes.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING BACTERIAL ANTIGENS | 2018 |
|
RU2689161C1 |
METHOD FOR PRODUCING STAPHYLOCOCCUS AUREUS ANTIGENS USING LYSOZYME AND LOW-MOLECULAR CHITOSAN | 2020 |
|
RU2740366C1 |
INACTIVATED VACCINE AGAINST INFECTIOUS MASTITIS AND ENDOMETRITIS IN COWS, METHOD FOR ITS PRODUCTION | 2024 |
|
RU2840041C1 |
IMMUNOBIOLOGICAL AGENT BASED ON RECOMBINANT PROTEIN FOR PREVENTING PNEUMOCOCCAL INFECTION | 2024 |
|
RU2823752C1 |
IMMUNOGENIC COMPOSITIONS OF STAPHYLOCOCCUS AUREUS ANTIGENS | 2010 |
|
RU2536981C9 |
METHODS FOR IDENTIFICATION, ISOLATION AND PRODUCTION OF ANTIGENS FOR SPECIFIC PATHOGEN | 2002 |
|
RU2289817C2 |
STAPHYLOCOCCUS AUREUS BACTERIA STRAIN "SAU-21L" FOR PRODUCTION OF BIOPREPARATIONS FOR SPECIFIC PREVENTION OF COW MASTITIS | 2023 |
|
RU2820305C1 |
PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES | 2010 |
|
RU2579900C2 |
IMMUNOGENIC COMPOSITION APPLICABLE FOR STAPHYLOCOCCUS VACCINATION | 2009 |
|
RU2521501C2 |
BIOFILM PREVENTION, DESTRUCTION AND TREATMENT BY BACTERIOPHAGE LYSIN | 2013 |
|
RU2646102C2 |
Authors
Dates
2025-05-12—Published
2023-11-10—Filed